Evidence map›Paper›PMID 42871208›Full record

ArticleClinical, cosmetic and investigational dermatology2026

Pathophysiologic Aspects of Dark Eye Circles and Impact on Associated Quality of Life in Participants with Various Fitzpatrick Skin Types.

Lisa T Goberdhan, Katie Schneider, Giovanni Pellacani, Brian Biesman, Tsing Cheng, Elizabeth Makino

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lisa T GoberdhanAllergan Aesthetics, an AbbVie Company, Irvine, CA, USA.
Katie SchneiderAllergan Aesthetics, an AbbVie Company, Irvine, CA, USA.
Giovanni PellacaniDermatology Clinic, Sapienza University of Rome, Rome, Italy.
Brian BiesmanDepartment of Ophthalmology, Dermatology, and Otolaryngology, Vanderbilt University Medical Center, Nashville, TN, USA.
Tsing ChengAllergan Aesthetics, an AbbVie Company, Irvine, CA, USA.
Elizabeth MakinoAllergan Aesthetics, an AbbVie Company, Irvine, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Dark eye circles (DECs) are a prevalent cosmetic concern for understanding the pathophysiological properties and etiology of DECs is crucial for effective treatment. This study assessed baseline DEC characteristics and associated quality of life (QOL) impacts in participants with varying DEC severities and Fitzpatrick Skin types (FSTs). Participants and Methods: Adult with DECs across FSTs were enrolled into this observational study. Assessments were grouped as follows: clinical (investigator grading of DEC severity, DEC type, and puffiness), biophysical (spectrophotometry, corneometry, tewametry, and BTC-2000 elasticity/laxity measurements), imaging (standardized photography, 3D imaging, and dynamic optical coherence tomography [D-OCT]), and patient-reported outcomes (FACE-Q and participant questionnaires). Results were summarized descriptively by DEC severity and FST; statistical testing was performed for D-OCT comparisons across FST groups. Results: All 42 participants who completed the study had at least mild DEC severity in both lower and upper eyelids, with severe DEC incidence similar on the upper and lower eyelid. Most exhibited multiple DEC types (ie, pigmented, vascular, shadow effect) and mild eye area puffiness. Participants with mild DECs had the highest mean eyelid skin elasticity. Participants with moderate DECs showed transepidermal water loss (TEWL) measurements suggestive of high hydration and barrier function in the lower eyelid skin. Participants of all DEC severities were bothered by their upper and lower eyelids. Those with severe DEC reported on the FACE-Q more negative perceptions of their facial skin age and eyelid appearance and were less confident or positive about their facial appearance. DEC severity was highest in participants with FST V-VI. Pigmented and shadow effect DECs were observed more in FST III-IV and V-VI, whereas vascular DECs appeared most in FST I-II. Spectrophotometer results showed that the difference between control and lower eyelid skin was broadly similar across FST groups. D-OCT revealed that the FST V-VI group had significantly thinner vascular networks, but significantly higher epidermal thickness (P < 0.05) than the other FST groups. Participants with FST V-VI felt more positive perceptions about their skin age; however, types III-IV and V-VI were more bothered by their lower eyelids than types I-II. Conclusion: DECs are present on the upper and lower eyelids and participants are bothered by both areas regardless of severity. DEC characteristics varied according to severity and FST and influenced participant-based perception of eyelid appearance, facial age, and confidence.

Indexed as

dark circleshyperpigmentationperiorbitalpuffinessunder eyeupper eyelids

Identifiers

PMID42871208
PMCPMC13658432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.